Kinetics of IgG-specific antibodies against chikungunya virus in a female cohort study in Brazil, 2018-2019
Authors:
- Lucas de Lima NogueiraLNLucas de Lima Nogueira
- Lucas Romão Alves VasconcelosLVLucas Romão Alves Vasconcelos
- Cristiane Cunha FrotaCFCristiane Cunha Frota
- Regis Bernardo Brandim GomesRGRegis Bernardo Brandim Gomes
- Clarissa Romero TeixeiraCTClarissa Romero Teixeira
- Shirlene Telmos Silva de LimaSLShirlene Telmos Silva de Lima
- Francisco Gustavo Silveira CorreiaFCFrancisco Gustavo Silveira Correia
- Paulo Rafael Cardoso de SousaPSPaulo Rafael Cardoso de Sousa
- Rafael Mota FerreiraRFRafael Mota Ferreira
- Francisco Marto Leal Pinheiro JuniorFJFrancisco Marto Leal Pinheiro Junior
- Adriano Ferreira MartinsAMAdriano Ferreira Martins
- Carlos Sanhueza-SanzanaCSCarlos Sanhueza-Sanzana
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 31 (6)
Abstract
The kinetics of IgG-specific antibody responses against chikungunya virus (CHIKV) is poorly understood. A total of 559 paired serum samples were collected at baseline and at first follow-up in a cohort of women aged 15-39 years from endemic areas of Fortaleza, Ceará State, following the major 2017 outbreak from February 2018 to August 2019. To estimate longitudinal seroprevalence, combining antibody markers (anti-CHIKV IgM and IgG) were screened by using enzyme-linked immunosorbent assays. We found an overall seroprevalence of 34% (190/559; 95%CI, 30.2-38.0) and 31.3% (175/559; 95%CI, 27.6-35.3) at baseline and first follow-up, respectively. Also, the distribution of seroprevalence did not differ significantly by age group [15-24 years, 35.4% (92/260); 25-39 years, 32.8% (98/299)]. Additionally, we found that median IgG level decreased over time across all age groups, and independent of prior history of symptomatic infection. We also observed four cases of seroreversion. Our findings provided valuable information regarding the decline of anti-CHIKV IgG levels in a post-epidemic scenario, highlighting the importance of serological surveillance to better understand the kinetics of antibody responses and to characterize epidemic risk.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (440778/2016-6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (312493/2021-5)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402403/2020-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (8887.130.795/2016-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (88881.130806/2016-01)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (3898920/2017)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (440778/2016-6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (312493/2021-5)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (402403/2020-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (8887.130.795/2016-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.130806/2016-01)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (3898920/2017)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Foundation to Support Scientific and Technological Development of Ceará (440778/2016-6)
- Foundation to Support Scientific and Technological Development of Ceará (312493/2021-5)
- Foundation to Support Scientific and Technological Development of Ceará (402403/2020-7)
- Foundation to Support Scientific and Technological Development of Ceará (8887.130.795/2016-00)
- Foundation to Support Scientific and Technological Development of Ceará (88881.130806/2016-01)
- Foundation to Support Scientific and Technological Development of Ceará (3898920/2017)
- Foundation to Support Scientific and Technological Development of Ceará (001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (440778/2016-6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (312493/2021-5)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (402403/2020-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (8887.130.795/2016-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.130806/2016-01)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (3898920/2017)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 31 references indexed in Scilit:
- Positivity of dengue, chikungunya, and Zika infections in women in Northeast Brazil post-Zika epidemicPathogens and Global Health, 2022
- Considering waning immunity to better explain dengue dynamicsEpidemics, 2022
- Rapid decline of Zika virus NS1 antigen-specific antibody responses, northeastern BrazilVirus Genes, 2020
- Influence of herd immunity in the cyclical nature of arbovirusesCurrent Opinion in Virology, 2020
- Defining a correlate of protection for chikungunya virus vaccinesVaccine, 2019
- Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural communityEmerging Microbes & Infections, 2018
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- Atypical manifestations of chikungunya infectionTransactions of the Royal Society of Tropical Medicine and Hygiene, 2010
- Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on RéunionEpidemiology and Infection, 2008
- Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposureProceedings of the National Academy of Sciences, 2005